Default
Allergy and immunology
Anaesthesia
Basic research
Cardiovascular medicine
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Dermatology
Emergency medicine
Endocrinology
Epidemiology
Ethics
Evidence-based medicine
Gastroenterology
Genetics
Geriatric medicine / aging
Haematology / blood transfusion
Health economics
Health policy
History of medicine
Infectious diseases
Internal medicine
Laboratory medicine
Legal and forensic medicine
Medical education
Medical informatics
Neurology
Nursing
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Oncology
Ophthalmology
Organisation of health care
Otolaryngology / head and neck surgery
Paediatrics
Palliative care
Pathology
Patient-physician relationship
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Psychosomatics
Public health
Quality of care
Radiology
Rehabilitation medicine
Renal medicine
Respiratory medicine
Rheumatology
Sexual medicine
Sports medicine
Statistics and research methods
Surgery
Transplantation
Travel medicine
Urology
Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 – survey results from the RH(E)IN-CARE network
Multidrug-resistant organisms are a public health threat. Single-centre interventions, however, are likely to fail in the long term, as patients are commonly transferred between institutions given the economic integration across borders. A transnational approach targeting larger regions is needed to plan overarching sets of interventions.
Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland
In cooperation with the Federal Office of Public Health, a surveillance database was set up in February 2020 to monitor hospitalised patients with COVID-19, in addition to their mandatory reporting system. The surveillance system has been successfully initiated and provides a robust set of data for Switzerland by including about 80% (compared with official statistics) of SARS-CoV-2/COVID-19 hospitalised patients, with similar age and comorbidity distributions. It adds detailed information on the epidemiology, risk factors and clinical course of these cases and, therefore, is a valuable addition to the existing mandatory reporting.
Distribution of low quality filtering facepiece respirators during the COVID-19 pandemic: an independent analysis of the situation in Switzerland
The demand for FFP respirators exceeded the supply capacity from established suppliers of the Swiss market. New production and import channels emerged, as did the number of poor-quality FFP respirators. FFP respirators remaining in stocks should be checked for conformity before being used, or eliminated and replaced if quality does not meet standards.
In the eye of the hurricane: the Swiss COVID-19 pandemic stepwise shutdown approach in organ donation and transplantation
The Swiss stepwise shutdown approach in organ donation and transplantation helped to maintain a limited national organ procurement and vital organ transplant activity, avoiding a complete nationwide shutdown of organ donation and transplant activity.
Impact of the COVID-19 pandemic on acute coronary syndromes
Prolonged delays from symptom onset to first medical contact and a decline in overall ACS incidence were observed during the first wave of the COVID-19 pandemic, with a higher threshold to call for help among ACS patients.
Towards novel reimbursement models for expensive advanced therapy medicinal products (ATMPs)
This article analyses the current legal framework in Switzerland and critically evaluates existing reimbursement models, particularly with respect to their adaptation for advanced therapy medicinal products. As a promising reimbursement arrangement, this paper proposes a model combining outcome-based instalment payments with aspects of the pay for performance and the annuity payment model.
Crisis of emerging antibiotic resistances mirroring that of the COVID-19 in the age of globalisation
Like to the COVID crisis, control of emerging antibiotic resistance genes requires early detection, rapid diagnosis, early intervention and development of novel antimicrobial agents. Epidemiological surveillance at the local level for emerging resistance at the molecular and biochemical levels is required.
Ventilatory weaning and early rehabilitation in COVID-19-related acute respiratory distress syndrome: the experience at Locarno hospital, canton of Ticino, Switzerland
The experience presented here, although limited, allows us to draw some important conclusions which may become useful in the current context of increasing numbers of COVID-19 patients needing hospitalisation.
Attitudes and acceptance of patients undergoing visceral surgery towards an open access electronic medical record – a Swiss-German single-centre study
The question of whether patients should have electronic access to their data has become one of the key topics under discussion.
The new remuneration system TARPSY in Swiss psychiatric hospitals: effects on length of stay and readmissions?
If being evident at all, the effects of the new remuneration system TARPSY on LOS and readmission rates seem to be small. Concerns that declining daily rates in TARPSY would result in early discharges and increased readmission rates did not prove true in adult and geriatric psychiatry.
